Dr. Cross is a Professor in Cancer Epidemiology in the Department of Epidemiology and Biostatistics within the School of Public Health, Faculty of Medicine of Imperial College. She is also the Head of the Cancer Screening and Prevention Research Group (http://csprg.org.uk) in the Department of Surgery and Cancer at Imperial.
She completed her PhD at Cambridge University and then obtained a post-doctoral fellowship within the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, United States. After two years of post-doctoral research, Dr. Cross was awarded a research fellowship and shortly after became a tenure-track investigator at NCI. During her time as an investigator at NCI, she was also a mentor for the Yale University– NCI Partnership Training Program and held the position of Assistant Professor Adjunct within the Division of Chronic Disease Epidemiology at Yale University, New Haven, Connecticut. Dr. Cross received the NIH Fellows Award for Research Excellence, the DCEG Fellowship Achievement Award for Outstanding Accomplishments, the DCEG Award for Outstanding Research Paper by a Fellow, the NCI Mentor of Merit Award, and the NIH Merit Award for Leadership of an Innovative Multidisciplinary Research Program.
Between 2005 and 2013, Dr. Cross was Principal Investigator of two colonoscopy screening studies (the Polyp Prevention Trial and the CONCeRN study), a metabolomics initiative within DCEG, and she was also one of the Principal Investigators of the U.S. Polyp Pooling Project. In 2013, Dr. Cross joined Imperial College to pursue her research interests in gastrointestinal malignancies and etiologic studies of lifestyle factors and cancer risk. She currently leads the Cancer Prevention and Early Detection theme in the Cancer Research UK centre at Imperial. In addition to her research commitments, she is co-Director of the MSc in Epidemiology at Imperial College.
et al., 2020, Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, International Journal of Cancer, Vol:146, ISSN:0020-7136, Pages:929-942
et al., 2020, British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines, Gut, Vol:69, ISSN:0017-5749, Pages:201-223
et al., 2019, Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses., Gastroenterology
et al., 2019, Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer., Gastroenterology
et al., Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study, Gut, ISSN:0017-5749